WS-50030

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameWS-50030
Drug Alias NameWS-50030
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsSchizophreniaDepressive Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsSchizophreniaDepressive Disorder

Other Information

ATC CodeN/A
Related LinksN/A